Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease

Abstract Systemic sclerosis (SSc) is a severe multi-organ disease with interstitial lung disease (ILD) being the major cause of death. While targeted therapies are emerging, biomarkers for sub-stratifying patients based on individual profiles are lacking. Herein, we investigated how levels of serum...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: C. Meier, K. Freiburghaus, C. Bovet, J. Schniering, Y. Allanore, O. Distler, C. Nakas, B. Maurer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/4f13a07c3c2549ea99406944b37d68ba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares